IPP Bureau
Ajooni Biotech awarded ZED certification by Ministry of MSME
By IPP Bureau - November 22, 2022
The company will reduce wastage substantially, increase productivity, enhance environmental consciousness, save energy, optimally use natural resources, and expand its market penetration
Alembic receives USFDA final approval for Nifedipine Extended-Release Tablets
By IPP Bureau - November 22, 2022
Nifedipine Extended-Release Tablets have an estimated market size of US $56 million for twelve months ending September 2022
Lupin signs MoU with Govt. of Rajasthan to strengthen healthcare system
By IPP Bureau - November 22, 2022
LHWRF will work with the State’s Department of Health and Family Welfare for strengthening the healthcare system and addressing the prevalence of CVD and COPD for better outcomes
Natural Biogenex completes its maiden fund-raise of Rs 18.75 Cr
By IPP Bureau - November 22, 2022
The proceeds from this fund-raise will be deployed in financing the project requirements of the API business
Merck to acquire Imago BioSciences for $1.35 bn
By IPP Bureau - November 22, 2022
Acquisition expands Merck’s growing hematology portfolio
Sonowal inaugurates Regional Research Institute of Unani Medicine in Silchar
By IPP Bureau - November 21, 2022
The newly built complex of RRIUM, which will be under CCRUM, the apex government organization for research in Unani Medicine
Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster
By IPP Bureau - November 21, 2022
Omicron BA.5 continues to be the most prevalent sublineage in the United States (nearly 30% of cases) at the time of publication of the data
Ayurveda tech startup NirogStreet raises US $12 mn led by Jungle Ventures
By IPP Bureau - November 21, 2022
The company offers a wide portfolio of services including integrated doctor-led prescription e-commerce enablement, digital health record management, and smart clinics.
USFDA completes pre-approval inspection of BHL's Vadodara facility
By IPP Bureau - November 21, 2022
The pre-approval inspection of USFDA was completed successfully with ZERO 483 observation of the manufacturing facilities of Bajaj Healthcare Limited
Aurobindo Pharma receives 10 observations for Unit IX
By IPP Bureau - November 21, 2022
The company had responded to the agency and carried out the required corrective actions.
Eugia Pharma receives USFDA approval for Amphotericin B Liposome for Injection
By IPP Bureau - November 19, 2022
The product is expected to be launched by Q4 FY23.
Strides receives USFDA approval for Potassium Chloride Oral Solution
By IPP Bureau - November 19, 2022
The approval further strengthens the Potassium Chloride franchise for the company.
Vivimed Labs Q2 FY2023 consolidated loss at Rs. 22.03 Cr
By IPP Bureau - November 19, 2022
The company has reported total income of Rs. 44.37 crores during the period ended September 30, 2022
Strand Life Sciences launches ‘Strand Genomic Wellness’
By IPP Bureau - November 18, 2022
Strand’s new offering will help people better understand and manage diseases through genomic sequencing
Apollo launches national program to promote rational use of antibiotics
By IPP Bureau - November 18, 2022
Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes
